1. Home
  2. WIX vs INDV Comparison

WIX vs INDV Comparison

Compare WIX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$51.10

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$40.48

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIX
INDV
Founded
2006
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
4.4B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
WIX
INDV
Price
$51.10
$40.48
Analyst Decision
Buy
Analyst Count
22
0
Target Price
$134.67
N/A
AVG Volume (30 Days)
1.3M
1.6M
Earning Date
05-13-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8100.00
EPS
N/A
0.69
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$15.80
N/A
Revenue Next Year
$13.21
N/A
P/E Ratio
$28.86
$56.70
Revenue Growth
N/A
4.29
52 Week Low
$40.00
$16.14
52 Week High
$190.92
$42.81

Technical Indicators

Market Signals
Indicator
WIX
INDV
Relative Strength Index (RSI) 51.15 52.62
Support Level $45.62 $39.20
Resistance Level $62.97 $41.00
Average True Range (ATR) 2.79 1.48
MACD 0.84 -0.23
Stochastic Oscillator 60.92 47.74

Price Performance

Historical Comparison
WIX
INDV

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: